A new review in Medical Oncology details how liquid biomarkers, advanced imaging, and artificial intelligence are transforming pre-biopsy discrimination of prostate cancer from benign disease.
Chinese researchers have built a machine-learning nomogram that combines biparametric MRI radiomics, clinical variables, and ...
A prostate biopsy can tell doctors whether cancer is present, but deciding where to take tissue samples has traditionally been difficult. MRI scans are changing that by helping doctors see suspicious ...
According to the U.S. Centers for Disease Control and Prevention, prostate cancer is the second leading cause of cancer death among men. One of the standard approaches for the diagnosis and treatment ...
Prostate cancer patients' adherence to medication while on abiraterone acetate (AA) therapy. This is an ASCO Meeting Abstract from the 2014 Genitourinary Cancers Symposium. This abstract does not ...
Each year, more than a million transrectal biopsies are performed in the United States. The primary technique for diagnosing and monitoring prostate cancer, a transrectal biopsy, entails removing ...
A team of researchers in Sweden has discovered that an artificial intelligence platform is capable of accurately diagnosing prostate cancer in tissue samples, offering the potential to speed up ...
Epidemiologic Analysis Along the Mevalonate Pathway Reveals Improved Cancer Survival in Patients Who Receive Statins Alone and in Combination With Bisphosphonates We compared the performance of 20 ...
LAS VEGAS (CN) - A federal jury on Thursday convicted Las Vegas urologist Michael Stanley Kaplan of reusing single-use needle guides while treating patients for prostate conditions. Kaplan, 59, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results